0000930413-11-002544.txt : 20110405
0000930413-11-002544.hdr.sgml : 20110405
20110405170423
ACCESSION NUMBER: 0000930413-11-002544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110403
FILED AS OF DATE: 20110405
DATE AS OF CHANGE: 20110405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HORAK IVAN D
CENTRAL INDEX KEY: 0001247903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12957
FILM NUMBER: 11740829
MAIL ADDRESS:
STREET 1: C/O IMMUNOMEDICS INC
STREET 2: 300 AMERICAN ROD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000727510
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222372868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 ROUTE 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908 541 8671
MAIL ADDRESS:
STREET 1: 685 ROUTE 202/206
STREET 2: ATT: GENERAL COUNSEL
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20021211
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20021210
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON INC
DATE OF NAME CHANGE: 19920703
4
1
c65105_form4.xml
X0303
4
2011-04-03
0
0000727510
ENZON PHARMACEUTICALS INC
ENZN
0001247903
HORAK IVAN D
C/O ENZON PHARMACEUTICALS, INC.
685 ROUTE 202/206
BRIDGEWATER,
NJ
08807
0
1
0
0
EVP, R&D, CSO
Common Stock
2011-04-03
4
M
0
26480
A
147856
D
Common Stock
2011-04-03
4
F
0
9380
11.02
D
138476
D
Restricted Stock Units
0
2011-04-03
4
M
0
16800
D
2011-04-03
2011-04-03
Common Stock
16800
0
D
Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
The Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.
/s/ Andrew Rackear, Attorney-In-Fact
2011-04-05